See more : Dish Network Corp. (EOT.DE) Income Statement Analysis – Financial Results
Complete financial analysis of BCAL Diagnostics Limited (BDX.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BCAL Diagnostics Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Automotive Finco Corp. (RMIAF) Income Statement Analysis – Financial Results
- BH Macro Limited (BHMU.L) Income Statement Analysis – Financial Results
- DILA Capital Acquisition Corp. (DILAW) Income Statement Analysis – Financial Results
- PIERER Mobility AG (PKTM.VI) Income Statement Analysis – Financial Results
- IC Plus Corp. (8040.TWO) Income Statement Analysis – Financial Results
BCAL Diagnostics Limited (BDX.AX)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Website: https://www.bcaldiagnostics.com
About BCAL Diagnostics Limited
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|---|
Revenue | 3.10M | 2.85M | 718.67K | 275.25K | 442.10K | 258.24K | 242.29K |
Cost of Revenue | 0.00 | 113.62K | 20.61K | 0.00 | 7.73K | 3.55K | 14.04K |
Gross Profit | 3.10M | 2.74M | 698.06K | 275.25K | 434.37K | 254.69K | 228.25K |
Gross Profit Ratio | 100.00% | 96.02% | 97.13% | 100.00% | 98.25% | 98.62% | 94.21% |
Research & Development | 4.36M | 3.23M | 1.12M | 664.11K | 466.77K | 205.39K | 251.90K |
General & Administrative | 1.64M | 2.35M | 1.87M | 249.04K | 176.85K | 136.91K | 144.28K |
Selling & Marketing | 238.26K | 194.82K | 130.36K | 887.07K | 34.12K | 337.26K | 1.62K |
SG&A | 4.18M | 2.54M | 2.00M | 1.14M | 663.96K | 474.17K | 438.35K |
Other Expenses | 0.00 | 2.79M | 700.03K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 8.55M | 7.90M | 4.10M | 1.80M | 1.13M | 679.55K | 690.25K |
Cost & Expenses | 8.55M | 7.90M | 4.10M | 1.80M | 1.14M | 683.11K | 704.29K |
Interest Income | 51.39K | 62.15K | 18.64K | 252.00 | 504.00 | 1.71K | 1.13K |
Interest Expense | 99.93K | 16.04K | 0.00 | 0.00 | 0.00 | 5.10K | 5.63K |
Depreciation & Amortization | 360.16K | 113.62K | 20.61K | 7.73K | 7.73K | 3.55K | 14.04K |
EBITDA | -5.67M | -7.72M | -4.06M | -1.80M | -1.03M | -677.84K | -690.25K |
EBITDA Ratio | -182.91% | -272.89% | -568.21% | -654.03% | -255.77% | -263.14% | -284.89% |
Operating Income | -5.45M | -7.90M | -4.10M | -1.80M | -1.14M | -683.10K | -704.29K |
Operating Income Ratio | -175.82% | -276.88% | -571.08% | -654.03% | -257.51% | -264.52% | -290.68% |
Total Other Income/Expenses | -4.00M | 2.84M | 718.67K | -866.05K | -349.71K | -265.18K | -4.50K |
Income Before Tax | -9.45M | -5.06M | -3.39M | -1.80M | -1.04M | -686.49K | -708.79K |
Income Before Tax Ratio | -304.93% | -177.44% | -471.08% | -653.94% | -234.87% | -265.83% | -292.54% |
Income Tax Expense | -3.05M | -46.11K | -18.64K | -275.00K | -341.98K | -256.53K | -241.15K |
Net Income | -6.40M | -5.06M | -3.39M | -1.52M | -696.36K | -429.96K | -467.63K |
Net Income Ratio | -206.58% | -177.44% | -471.08% | -554.03% | -157.51% | -166.49% | -193.01% |
EPS | -0.03 | -0.02 | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.03 | -0.02 | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 246.16M | 210.90M | 204.29M | 215.14M | 215.14M | 215.14M | 215.14M |
Weighted Avg Shares Out (Dil) | 246.23M | 210.90M | 204.29M | 215.14M | 215.14M | 215.14M | 215.14M |
Source: https://incomestatements.info
Category: Stock Reports